Akorn Quick ratio
Quel est le Quick ratio de Akorn?
Le Quick ratio de Akorn, Inc. est 0.30
Quelle est la définition de Quick ratio?
«Quick ratio» est le ratio de liquidité qui mesure la capacité d'une entreprise à utiliser ses actifs rapides pour faire face à ses obligations à court terme immédiatement.
The quick ratio is the ratio between quick or liquid assets and current liabilities. Quick assets include those current assets that presumably can be quickly converted to cash at close to their book values. A normal liquid ratio is considered to be 1. A company with a quick ratio of less than 1 cannot at the time fully pay its current liabilities or short-term obligations. This ratio is considered to be a much reliable tool for assessment of liquidity position of companies.
Quick ratio des entreprises dans Health Care secteur sur OTC par rapport à Akorn
Que fait Akorn?
Akorn, Inc., a specialty pharmaceutical company, develops, manufactures, and markets generic and branded prescription pharmaceuticals, over-the-counter (OTC) consumer health products, and animal health pharmaceuticals in the United States and internationally. The company operates in two segments, Prescription Pharmaceuticals and Consumer Health. The Prescription Pharmaceuticals segment offers generic and branded prescription pharmaceuticals in various dosage forms, including sterile ophthalmics, injectables, and inhalants; and non-sterile oral liquids, topicals, nasal sprays, and otics. Its primary products include Akten, a topical ocular anesthetic gel; AzaSite, an antibiotic used to treat bacterial conjunctivitis; Cosopt, Cosopt PF, Betimol, and Zioptan, which are used in the treatment of glaucoma; and Xopenex inhalation solution used in the treatment or prevention of bronchospasm. The Consumer Health segment manufactures and markets OTC products for the treatment of dry eye under the TheraTears brand. It also markets other OTC consumer health products comprising Mag-Ox, a magnesium supplement; and the Diabetic Tussin line of cough and cold products. In addition, this segment offers a portfolio of animal health products, such as Anased and VetaKet veterinary sedatives; Tolazine and Yobine sedative reversing agents; and Butorphic, a pain reliever. Further, the company sells its products to wholesale distributors. Akorn, Inc. was founded in 1971 and is headquartered in Lake Forest, Illinois. On May 20, 2020, Akorn, Inc., along with its affiliates, filed a voluntary petition for reorganization under Chapter 11 in the U.S. Bankruptcy Court for the District of Delaware.
Entreprises avec quick ratio similaire à Akorn
- Rosier SA a Quick ratio de 0.30
- Clough Global Opportunities Fund a Quick ratio de 0.30
- Dream Industrial Real Estate Investment Trust a Quick ratio de 0.30
- Monnet Ispat & a Quick ratio de 0.30
- Kingfisher plc a Quick ratio de 0.30
- Gemini Investments () a Quick ratio de 0.30
- Akorn a Quick ratio de 0.30
- PT XL Axiata Tbk a Quick ratio de 0.30
- Banco Itau Chile a Quick ratio de 0.30
- Future Market Networks a Quick ratio de 0.30
- Future Market Networks a Quick ratio de 0.30
- Varun Beverages a Quick ratio de 0.30
- India Steel Works a Quick ratio de 0.30